Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

New England Journal of Medicine

Volumn 345, Issue 22, 2001, Pages 1593-1600

  Schnyder, Guido ^a,c   Roffi, Marco ^a   Pin, Riccardo ^a   Flammer, Yvonne ^a   Lange, Helmut ^b   Eberli, Franz R ^a   Meier, Bernhard ^a   Turi, Zoltan G ^c   Hess, Otto M ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Kardiologische Praxis   (Germany)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SAFETY; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PYRIDOXINE; VITAMIN B 12;

EID: 0035969545     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011364     Document Type: Article

References (35)

1. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months
2. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
3. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
4. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty
5. Local delivery of enoxaparin to decrease restenosis after stenting: Results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (the POLONIA study)
6. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
7. Homocysteine, B vitamins, and coronary artery disease
8. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis
9. Association of plasma homocysteine with the number of major coronary arteries severely narrowed
10. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
11. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle
12. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
13. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
14. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
15. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty
16. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials
17. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
18. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
19. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection
20. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease
21. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
22. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)
23. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis
24. Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation: Implications for patient selection
25. Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions
26. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
27. Homocysteine as a risk factor for vascular disease: Enhanced collagen production and accumulation by smooth muscle cells
28. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
29. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
30. Tissue plasminogen activator binding to the annexin II tail domain: Direct modulation by homocysteine
31. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells
32. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
33. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
34. Low circulation folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
35. Studies on the effect of platelet inhibiors on platelet adhesion to collagen and collagen-induced human platelet activation